| Application no. and date | 07818583.2 (espacenet) (Federated) (European Patent Register), 20070929 | | Patent/reg. no. and date | DK/EP 2097381, 20130619 | | Publication date | 20090909 | | Priority no. and date | EP 06021296, 20061011 | | EP pub. no. and date |
EP 2097381 20090909 | | Effective date | | | Applicant/owner | Bayer HealthCare LLC, 555 White Plains Road
Tarrytown, NY 10591, US | | Applicant ref. no. | BBS BHC061143 | | Inventor | GRUNENBERG, Alfons, Gneisenaustrasse 15
41539 Dormagen, DE,
KEIL, Birgit, Sudetenstrasse 36
40231 Düsseldorf, DE,
STIEHL, Juergen, Rosenstrasse 28
45549 Sprockhövel, DE,
TENBIEG, Katharina, Busenbergstrasse 103
44269 Dortmund, DE | | Representative | RWS Group, RWS Compass House
Vanwall Business Park, Vanwall Road
Maidenhead, Berkshire
SL6 4UB, GB | | Opponent | | | IPC Class | A61K 31/44 (2006.01) , A61P 35/00 (2006.01) , C07D 213/81 (2006.01) | | Title | 4-[4-({[4-chlor-3-(trifluormethyl)phenyl)]carbamoyl}amino)-3-fluorphenoxy]-N-methylpyridin-2-carboxamidmonohydrat | | Int. application no. | EP2007008503 | | Int. publication no. | WO2008043446 | | Related patent (certificate) | | | Status | DK/EP patent | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
